1. Bobrow RS. Benzodiazepines revisited. Family Practice 2003; 20: 347–349.

2. Clinical guidelines for the use of benzodiazepines among patients receiving medication – assisted treatment for opioid dependence. Baltimore Substance Abuse Systems, Inc. May 2013 http://www. bhsbaltimore.org/site/wp-content/uploads/2013/09/Benzo-Guidelines- FINAL-May-2013.pdf

3. Kostowski W, Herman Z. Farmakologia. Podstawy farmakoterapii. PZWL. Warszawa 2010.

4. Sobów T. Benzodiazepiny u pacjentów w podeszłym wieku. Medycyna Wieku Podeszłego 2012; 2(1): 1-6.

5. Bostwick JR, Casher MI, Yasugi S. Benzodiazepines: A versatile clinical tool. Curr Psychiatr 2012; 11(4): 55-63.

6. Bandelow B, Zohar J, Hollander E, et al. World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the pharmacological treatment of anxiety, obsessive-compulsive and post-traumatic stress disorders - first revision. World J Biol Psychiatry. 2008;9(4):248-312.

7. Ballenger JC, Davidson JR, Lecrubier Y, et al. Consensus statement update on posttraumatic stress disorder from the international consensus group on depression and anxiety. J Clin Psychiatry. 2004;65(suppl 1):55-62.

8. A consensus statement on the use of benzodiazepines in specialist mental health services. EAP 03/2012 Position Paper. College of Psychiatry of Ireland June 2012.

9. Schutte-Rodin S, Broch L, Buysse D, et al. Clinical guideline for the evaluation and management of chronic insomnia in adults. J Clin Sleep Med. 2008;4(5):487-504.

10. Ashton H. Guidelines for the rational use of benzodiazepines. When and what to use. Drugs. 1994 Jul;48(1):25-40. www.benzo.org.uk

11. Mehdi T. Benzodiazepines revisited. BJMP 2012;5(1):a501. http:// www.bjmp.org/content/benzodiazepines-revisited

12. Guidelines for the use of benzodiazepines in office practice in the state of Maine. http://www.benzos.une.edu/documents/prescribingguidelines3- 26-08.pdf

13. Wheatley, D. Effects of drugs on sleep. In Psychopharmacology of sleep. Wheatley D, ed. New York: Raven Press, 1981; 153-176.

14. Lader, M. The present status of benzodiazepines and psychiatry and medicine. Drug Res 1980; 30:910-913.

15. Rickels, K. Use of anti-anxiety drugs and anxious outpatients. Psychopharmacology 1978; 58:1-17.

16. Greenblatt, D.J & Shader RI: Benzodiazepines in Clinical Practice. New York, Raven Press, 1974.

17. Hidalgo RB, Tupler LA, Davidson JR. An effect-size analysis of pharmacologic treatments of generalized anxiety disorder. J Psychopharmacol. 2007;21(8):864-872.

18. Pollack MH, Simon NM, Worthington JJ, et al. Combined paroxetine and clonazepam treatment strategies compared to paroxetine monotherapy for panic disorder. J Psychopharmacol. 2003;17(3):276-282.

19. Otto MW, McHugh RK, Simon NM, et al. Efficacy of CBT for benzodiazepine discontinuation in patients with panic disorder: further evaluation. Behav Res Ther. 2010;48(8):720-727.

20. Davidson JR. Use of benzodiazepines in social anxiety disorder generalized anxiety disorder, and posttraumatic stress disorder. J Clin Psychiatry. 2004;65(suppl 5):29-33.

21. Connor KM, Davidson JR, Potts NL, et al. Discontinuation of clonazepam in the treatment of social phobia. J Clin Psychopharmacol. 1998;18(5):373-378.

22. Melton ST, Kirkwood CK. Anxiety disorders I: generalized anxiety panic, and social anxiety disorders. In: DiPiro JT, Talbert RL, Yee GC, et al, eds. Pharmacotherapy: a pathophysiologic approach. New York, NY: McGraw -Hill Companies; 2011:1209-1228.

23. Menon SJ. Psychotropic medication during pregnancy and lactation. Arch Gynecol Obstet. 2008;277(1):1-13.

24. Benzodiazepines. Good practice guidelines for clinicians. National Documentation Centre on Drug Use. Ireland. http://www.drugsandalcohol. ie/5349/1/1500-1388.pdf

25. Makowska I. Farmakoterapia bezsenności. Lek w Polsce. 2014; 276(4): 14-20.

26. Heffron WA., Roth P., Double-blind evaluation of the safety and hypnotic efficacy of temazepam in insomniac outpatients. Br J Clin Pharmacol 1979; 8(Suppl 1): 69S–72S.

27. Luks AM. Which medications are safe and effective for improving sleep at high altitude? High Alt Med Biol. 2008 Fall;9(3):195-8.

28. Agarwal V, Kommaddi RP, Valli K, i wsp. Drug metabolism in human brain: high levels of cytochrome P4503A43 in brain and metabolism of anti-anxiety drug alprazolam to its active metabolite. PLoS One. 2008 Jun 11;3(6):e2337.

29. Mendelson WB. Medications in the treatment of sleep disorders. In: Meltzer HY, editor. Psychopharmacology: the third generation of progress. New York: Raven Press. 1987: 1305-11.

30. Lader M. Avoiding long-term use of benzodiazepine drugs;. Prescriber March 1991; 79-83. 31. Morawiec S. Leczenie zaburzeń lękowych. Gabinet Prywatny 2014; 233(1): 51-61.